The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair
Abstract
Functional recovery following peripheral nerve injury is limited by progressive atrophy of denervated muscle and Schwann cells (SCs) that occurs during the long regenerative period prior to end-organ reinnervation. Insulin-like growth factor 1 (IGF-1) is a potent mitogen with well-described trophic and anti-apoptotic effects on neurons, myocytes, and SCs. Achieving sustained, targeted delivery of small protein therapeutics remains a challenge. We hypothesized that a novel nanoparticle (NP) delivery system can provide controlled release of bioactive IGF-1 targeted to denervated muscle and nerve tissue to achieve improved motor recovery through amelioration of denervation-induced muscle atrophy and SC senescence and enhanced axonal regeneration. Biodegradable NPs with encapsulated IGF-1/dextran sulfate polyelectrolyte complexes were formulated using a flash nanoprecipitation method to preserve IGF-1 bioactivity and maximize encapsulation efficiencies. Under optimized conditions, uniform PEG-b-PCL NPs were generated with an encapsulation efficiency of 88.4%, loading level of 14.2%, and a near-zero-order release of bioactive IGF-1 for more than 20 days in vitro. The effects of locally delivered IGF-1 NPs on denervated muscle and SCs were assessed in a rat median nerve transection-without- repair model. The effects of IGF-1 NPs on axonal regeneration, muscle atrophy, reinnervation, and recovery of motor function were assessed in a model in which chronic denervation is induced prior to nerve repair. IGF-1 NP treatment resulted in significantly greater recovery of forepaw grip strength, decreased denervation-induced muscle atrophy, decreased SC senescence, and improved neuromuscular reinnervation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin-like growth factor 1 (IGF-1) induces a neuroprotective effect by effectively inhibiting neuronal apoptosis and promoting neural cell survival and regeneration (Bhalla et al., 2022; Hanwright et al., 2022).”
From Complex bioactive nanofibrous dura mater repairs traumatic brain injury (2026) · cites this paper as Hanwright et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540
Improving peripheral nerve regeneration: From molecular mechanisms to potential therapeutic targets
Chan, K. M., Gordon, T., Zochodne, D. W., & Power, H. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.006 · Cited by 189
Research works printed but not linked: 51
- Taylor, 2008, The incidence of peripheral nerve injury in extremity trauma, Am. J. Phys. Med. Rehabil., 87, 381, 10.1097/PHM.0b013e31815e6370 · DOI · Paper page
- Bruyns, 2003, Predictors for return to work in patients with median and ulnar nerve injuries, J. Hand Surg., 28, 28, 10.1053/jhsu.2003.50026 · DOI · Paper page
- Carlson, 1996, Studies on the regenerative recovery of long-term denervated muscle in rats, Restor. Neurol. Neurosci., 10, 77
- Grinsell, 2014, Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies, BioMed Res. Int., 2014, 698256, 10.1155/2014/698256 · DOI · Paper page
- Sulaiman, 2000, Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size, Glia, 32, 234, 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3 · DOI · Paper page
- Gordon, 2011, The basis for diminished functional recovery after delayed peripheral nerve repair, J. Neurosci., 31, 5325, 10.1523/JNEUROSCI.6156-10.2011 · DOI · Paper page
- Feldman, 1997, Insulin-like growth factors regulate neuronal differentiation and survival, Neurobiol. Dis., 4, 201, 10.1006/nbdi.1997.0156 · DOI · Paper page
- Kanje, 1989, Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve, Brain Res., 486, 396, 10.1016/0006-8993(89)90531-3 · DOI · Paper page
- Apel, 2010, Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats, Muscle Nerve, 41, 335, 10.1002/mus.21485 · DOI
- Ishii, 1994, Role of insulin-like growth factors in peripheral nerve regeneration, Pharmacol. Ther., 62, 125, 10.1016/0163-7258(94)90007-8 · DOI
- Shavlakadze, 2005, Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy, Neuromuscul. Disord., 15, 139, 10.1016/j.nmd.2004.10.013 · DOI
- Stitt, 2004, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors, Mol. Cell., 14, 395, 10.1016/S1097-2765(04)00211-4 · DOI · Paper page
- Heszele, 2004, Insulin-like growth factor I: the yin and yang of muscle atrophy, Endocrinology, 145, 4803, 10.1210/en.2004-1037 · DOI
- Delaney, 2001, Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells, J. Neuropathol. Exp. Neurol., 60, 147, 10.1093/jnen/60.2.147 · DOI
- Schumacher, 1993, Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP, Glia, 8, 232, 10.1002/glia.440080403 · DOI
- Yan, 2018, Anti-apoptotic effect of IGF1 on Schwann exposed to hyperglycemia is mediated by neuritin, a novel neurotrophic factor, Mol. Neurobiol., 55, 495, 10.1007/s12035-016-0331-3 · doi:10.1007/s12035-016-0331-3
- Cheng, 2000, IGF-I promotes Schwann cell motility and survival via activation of Akt, Mol. Cell. Endocrinol., 170, 211, 10.1016/S0303-7207(00)00324-5 · DOI
- Tuffaha, 2016, Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury, Expert Opin. Ther. Targets, 20, 1259, 10.1080/14728222.2016.1188079 · DOI
- Ishii, 1993, Regulation of peripheral nerve regeneration by insulin-like growth factors, Ann. N. Y. Acad. Sci., 692, 172, 10.1111/j.1749-6632.1993.tb26215.x · doi:10.1111/j.1749-6632.1993.tb26215.x
- Tuffaha, 2016, Growth hormone therapy accelerates axonal regeneration, promotes motor reinnervation, and reduces muscle atrophy following peripheral nerve injury, Plast. Reconstr. Surg., 137, 1771, 10.1097/PRS.0000000000002188 · DOI
- Bianchi, 2017, Neurotrophic and neuroregenerative effects of GH/IGF1, Int. J. Mol. Sci., 18, 2441, 10.3390/ijms18112441 · DOI · Paper page
- Saceda, 2011, Effect of recombinant human growth hormone on peripheral nerve regeneration: experimental work on the ulnar nerve of the rat, Neurosci. Lett., 504, 146, 10.1016/j.neulet.2011.09.020 · doi:10.1016/j.neulet.2011.09.020
- Lopez, 2019, Growth hormone improves nerve regeneration, muscle re-innervation, and functional outcomes after chronic denervation injury, Sci. Rep., 9, 3117, 10.1038/s41598-019-39738-6 · DOI
- Sjoberg, 1989, Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve, Brain Res., 485, 102, 10.1016/0006-8993(89)90671-9 · DOI · Paper page
- Kanje, 1991, Does insulin-like growth factor I (IGF-1) trigger the cell body reaction in the rat sciatic nerve?, Brain Res., 563, 285, 10.1016/0006-8993(91)91547-E · doi:10.1016/0006-8993(91)91547-e
- Emel, 2011, Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model, J. Neurosurg., 114, 522, 10.3171/2010.9.JNS091928 · DOI
- Tiangco, 2001, IGF-I and end-to-side nerve repair: a dose-response study, J. Reconstr. Microsurg., 17, 247, 10.1055/s-2001-14516 · doi:10.1055/s-2001-14516
- Fansa, 2002, Influence of insulin-like growth factor-I (IGF-I) on nerve autografts and tissue-engineered nerve grafts, Muscle Nerve, 26, 87, 10.1002/mus.10165 · DOI
- Tae, 2006, PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor, J. Biomater. Sci. Polym. Ed., 17, 187, 10.1163/156856206774879090 · DOI
- Wang, 2018, Enzymatically cross-linked hydrogels based on a linear poly (ethylene glycol) analogue for controlled protein release and 3D cell culture, J. Mater. Chem. B, 6, 6067, 10.1039/C8TB01949E · DOI
- Tang, 2018, Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery, Nat. Biotechnol., 36, 707, 10.1038/nbt.4181 · DOI · Paper page
- He, 2019, Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes, J. Contr. Release, 301, 119, 10.1016/j.jconrel.2019.03.014 · DOI
- Xu, 2017, High strength astringent hydrogels using protein as the building block for physically cross- linked multi-network, ACS Appl. Mater. Interfaces, 10, 7593, 10.1021/acsami.7b04290 · DOI
- Majumder, 2019, Nanocarrier-based systems for targeted and site specific therapeutic delivery, Adv. Drug Deliv. Rev., 144, 57, 10.1016/j.addr.2019.07.010 · DOI · Paper page
- Park, 2012, Multi-arm histidine copolymer for controlled release of insulin from poly (lactide-co-glycolide) microsphere, Biomaterials, 33, 8848, 10.1016/j.biomaterials.2012.08.042 · DOI
- Johnson, 2003, Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer, Aust. J. Chem., 56, 1021, 10.1071/CH03115 · DOI · Paper page
- Markwalter, 2018, Design of a small-scale multi-inlet vortex mixer for scalable nanoparticle production and application to the encapsulation of biologics by inverse flash nanoprecipitation, J. Pharmacol. Sci., 107, 2465, 10.1016/j.xphs.2018.05.003 · DOI
- Markwalter, 2020, Polymeric nanocarrier formulations of biologics using inverse flash nanoprecipitation, AAPS J., 22, 1, 10.1208/s12248-019-0405-z · DOI
- He, 2018, Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery, Acta Biomater., 81, 195, 10.1016/j.actbio.2018.09.047 · DOI
- He, 2019, Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes, J. Contr. Release, 301, 119, 10.1016/j.jconrel.2019.03.014 · DOI
- Hunter, 2009, Insulin/IGF‐1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function, J. Thromb. Haemostasis, 7, 2123, 10.1111/j.1538-7836.2009.03637.x · DOI
- Hanwright, 2019, Stimulated grip strength measurement: validation of a novel method for functional assessment, Muscle Nerve, 60, 437, 10.1002/mus.26646 · doi:10.1002/mus.26646
- Glazner, 1995, Insulin-like growth factor gene expression in rat muscle during reinnervation, Muscle Nerve, 18, 1433, 10.1002/mus.880181214 · DOI
- Stewart, 1996, Regulation of rat Schwann cell Po expression and DNA synthesis by insulin-like growth factors in vitro, Eur. J. Neurosci., 8, 553, 10.1111/j.1460-9568.1996.tb01240.x · DOI
- Fex, 1996, Insulin and the insulin-like growth factors I and II are mitogenic to cultured rat sciatic nerve segments and stimulate [3H]-thymidine incorporation through their respective receptors, Glia, 18, 68, 10.1002/(SICI)1098-1136(199609)18:1<68::AID-GLIA7>3.0.CO;2-# · DOI
- Caroni, 1990, Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors, J. Cell Biol., 110, 1307, 10.1083/jcb.110.4.1307 · DOI · Paper page
- Raimondo, 2019, Combined delivery of VEGF and IGF-1 promotes functional innervation in mice and improves muscle transplantation in rabbits, Biomaterials, 216, 119246, 10.1016/j.biomaterials.2019.119246 · DOI
- Lehmann, 2012, Human Schwann cells retain essential phenotype characteristics after immortalization, Stem Cell. Dev., 21, 423, 10.1089/scd.2010.0513 · doi:10.1089/scd.2010.0513
- Wen, 1985, MyoVision: software for automated high-content analysis of skeletal muscle immunohistochemistry, J. Appl. Physiol., 124, 40, 10.1152/japplphysiol.00762.2017 · DOI · Paper page
- Kern, 2017, A novel rodent orthotopic forelimb transplantation model that allows for reliable assessment of functional recovery resulting from nerve regeneration, Am. J. Transplant., 17, 622, 10.1111/ajt.14007 · doi:10.1111/ajt.14007
- Sulaiman, 2009, Role of chronic Schwann cell denervation in poor functional recovery after nerve injuries and experimental strategies to combat it, Neurosurgery, 65, A105, 10.1227/01.NEU.0000358537.30354.63 · DOI
Cited by
Complex bioactive nanofibrous dura mater repairs traumatic brain injury
Chen, S., Zhang, X., Guo, Q., Yan, Y., Fu, M., Wang, Y., & Wu, T. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00621 · Cited by 3
Metadata
- Authors
- Hanwright, P. J., Qiu, C., Rath, J., Zhou, Y., von Guionneau, N., Sarhane, K. A., Harris, T. G. W., Howard, G. P., Malapati, H., Lan, M. J., Reddy, S., Hoke, A., Mao, H.-Q., & Tuffaha, S. H.
- ORCID
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 280
- Pages
- 121244
- ISSN
- 0142-9612
- Cited by
- 57
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 727 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair. https://app.cochat.ai/papers/10.1016/j.biomaterials.2021.121244
- The paper
- Hanwright, P. J., Qiu, C., Rath, J., Zhou, Y., von Guionneau, N., Sarhane, K. A., Harris, T. G. W., Howard, G. P., Malapati, H., Lan, M. J., Reddy, S., Hoke, A., Mao, H.-Q., & Tuffaha, S. H. (2022). Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair. Biomaterials. https://doi.org/10.1016/j.biomaterials.2021.121244
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.